Skip to main content

Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial

Publication ,  Conference
DeAngelo, DJ; Yin, J; Advani, AS; Luger, S; Fulcher, J; Liedtke, M; Uy, GL; Dinner, SN; Wilde, L; Luskin, MR; Saygin, C; Postich, E; Teske, R ...
Published in: Blood
November 5, 2024

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

308 / 308

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DeAngelo, D. J., Yin, J., Advani, A. S., Luger, S., Fulcher, J., Liedtke, M., … Stock, W. (2024). Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. In Blood (Vol. 144, pp. 308–308). American Society of Hematology. https://doi.org/10.1182/blood-2024-209438
DeAngelo, Daniel J., Jun Yin, Anjali S. Advani, Selina Luger, Jill Fulcher, Michaela Liedtke, Geoffrey L. Uy, et al. “Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial.” In Blood, 144:308–308. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-209438.
DeAngelo DJ, Yin J, Advani AS, Luger S, Fulcher J, Liedtke M, et al. Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. In: Blood. American Society of Hematology; 2024. p. 308–308.
DeAngelo, Daniel J., et al. “Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 308–308. Crossref, doi:10.1182/blood-2024-209438.
DeAngelo DJ, Yin J, Advani AS, Luger S, Fulcher J, Liedtke M, Uy GL, Dinner SN, Wilde L, Luskin MR, Saygin C, Postich E, Fulton N, Harvey RC, Perez Burbano GE, Teske R, Erba HP, Litzow MR, Stone RM, Stock W. Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial. Blood. American Society of Hematology; 2024. p. 308–308.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 5, 2024

Volume

144

Issue

Supplement 1

Start / End Page

308 / 308

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology